Delving into the Latest Updates on ZHB601 with Synapse

Overview

Basic Info

Drug Type

Chemical drugs

Synonyms

Target-

Action-

Mechanism-

Therapeutic Areas

Nervous System DiseasesCardiovascular Diseases

Active Indication

Cerebral Small Vessel Diseases

Inactive Indication-

Originator Organization

Zonhon Biopharma Institute, Inc.

Active Organization

Zonhon Biopharma Institute, Inc.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

Primary objective: To evaluate the safety and tolerability of single and multiple subcutaneous administration of ZHB601 for injection in healthy subjects. Secondary objective: To evaluate the PK characteristics of single and multiple subcutaneous administration of ZHB601 for injection in healthy subjects. To evaluate the immunogenicity of single and multiple subcutaneous administration of ZHB601 for injection in healthy subjects.

Start Date-

Sponsor / Collaborator

Zonhon Biopharma Institute, Inc.

100 Clinical Results associated with ZHB601

Login to view more data

100 Translational Medicine associated with ZHB601

Login to view more data

100 Patents (Medical) associated with ZHB601

Login to view more data

100 Deals associated with ZHB601

Login to view more data